Research using rabbits with heart disease has shown that NOX4 interacts with Smad 2/3 to regulate TGF-β signalling thereby indirectly determining fibroblast to myofibroblast differentiation and inhibition of NOX4 was shown to have the potential as an efficacious therapy for heart disease [14]. This evidence concerns the gene TGFB1 and heart disorder.